An atypical presentation of a blastic plasmacytoid dendritic cell tumors

Journal of Cutaneous Pathology

Volumn 37, Issue 9, 2010, Pages

  López, Verónica ^a   Martí, Nuria ^a   Ferrández, Antonio ^a   Martin, Jose María ^a   Jordá, Esperanza ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COP PROTOCOL 2; CYCLOPHOSPHAMIDE; PREDNISONE; TUMOR MARKER; VINCRISTINE;

AGED; ARTICLE; BONE MARROW CELL; CASE REPORT; DENDRITIC CELL; FATALITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; SKIN TUMOR;

AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; BONE MARROW CELLS; CYCLOPHOSPHAMIDE; DENDRITIC CELLS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; PREDNISONE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 77954486839     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2009.01334.x     Document Type: Article

References (14)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768.
2. Chan JK, Sin VC, Wong KD, et al. Non-nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997 89 : 4501.
3. Russell-Jones R. World Health Organization classification of hematopoietic and lymphoid tissues: implications for dermatology. J Am Acad Dermatol 2003 48 : 93.
4. Petrella T, Dalac S, Maynadie M, et al. CD4+ CD56+ cutaneous neoplasms: a distinct haematological entity; groupe Francais detude des lymphomas cutanes (GFELC). Am J Surg Pathol 1999 23 : 137.
5. DiGiuseppe JA, Louie C, Williams JE, et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol 1997 21 : 1223.
6. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM) positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory trat. Am J Surg Pathol 1995 19 : 284.
7. Koashi Y, Nakamura S, Sasajima Y, et al. Inconsistent association of Ebstein-Barr virus with CD56 (NCAM) positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Histopathology 1996 28 : 111.
8. Sra KK, Waguespack-LaBiche J, Rapini R, Jordon R, Raimer S. T/natural killer-cell lymphomas. J Am Acad Dermatol 2005 52 : 708.
9. Radonich MA, Lazova R, Bolognia J. Cutaneous natural killer/T-cell lymphoma. J Am Acad Dermatol 2002 46 : 451.
10. Jaffe ES, Hrris NL, Stein H, Vardiman JW. World Health Organization classification of tumours, pathology & genetics tumours of the haematopoietic and lymphoid tissues.
11. Matano S, Nakamura S, Nakamura S, et al. Monomorphic agranular natural killer lymphoma/leukaemia with no Epstein-Barr virusassociation. Acta Hematologica 1999 101 : 206.
12. Petrella T, Comeau MR, Maynadie M, et al. Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ prculsor cells related to plasmocytoid monocytes. Am J Surg Pathol 2002 26 : 852.
13. Marafioti T, Paterson JC, Ballabio E, et al. Novel markers of normal and neoplastic human plasmocytoid dendritic cells. Blood 2008 111 : 3778.
14. Jacob MC, Chaperot L, Mosuz P, et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmocytoid dendritic cells. Haematologica 2003 88 : 941.